HealthGPT? Benefits, Risks, and Effective Uses of Generative AI in Medtech

Greenberg Traurig Shareholder A.J. Tibbetts will be a panelist during the MASSMedic webinar, "HealthGPT? Benefits, Risks, and Effective Uses of Generative AI in Medtech," on Tuesday, May 2 at 1:00 p.m. EST. The session will discuss the current wave of Generative AI products and their potential impact on the medical industry. The program will also discuss the business case in medtech for this revolutionary technology, including what the tech is, how it could be put to promising use in healthcare, and healthcare applications/problems where AI may not yet be ripe for deployment and where other solutions may still be best. Panelists will also offer legal points to have in mind when building your tech or choosing a service, including what to look for in terms of service and privacy policies.